Skip to main content
  • Home
  • Articles
    • Archive from 2022 July
    • Archive 1960 to 2022 June
    • Accepted Articles
    • Published Ahead-of-Print
    • Supplement
  • About
  • For Authors
  • Podcasts

Carbimazole-induced myositis in the treatment of Graves' disease: a complication in genetically susceptible individuals?

< Back to Listing

Share this Article

Singapore Med J 2013; 54(7): e133-e136; http://dx.doi.org/10.11622/smedj.2013145
Carbimazole-induced myositis in the treatment of Graves' disease: a complication in genetically susceptible individuals?

  • Abstract
  • PDF
  • References

Lim AY, Kek PC, Soh WE
Correspondence: Dr Adoree Yi Ying Lim, adoree.lim.y.y@sgh.com.sg

ABSTRACT
A 24-year-old Chinese woman with Graves’ disease presented with myositis two months after treatment with carbimazole. The patient’s myositis resolved with hydration and cessation of carbimazole. No other causes of myositis were found, and a change in the medication to propylthiouracil was uneventful. Review of the literature suggests a possible genetic susceptibility, as the majority of reported cases are Asian in origin, similar to patients who present with thyroid periodic paralysis. Changing the antithyroid drugs (ATDs) administered, decreasing the dose of pre-existing ATDs in the treatment regimen or addition of levothyroxine has been shown to result in clinical improvement of this complication. These observations suggest various mechanisms of carbimazole-induced myositis in the treatment of Graves’ disease, including the direct effect of ATDs on myocytes, immune-related responses secondary to ATDs and rapid decrements in thyroid hormonewith ensuing myositis.

Keywords: antithyroid drugs, carbimazole, complications in the treatment of thyrotoxicosis, myositis, Graves’ disease
Singapore Med J 2013; 54(7): e133–e136; http://dx.doi.org/10.11622/smedj.2013145

http://smj.org.sg/sites/default/files/5407/5407cr1.pdf

REFERENCES

1. Swanson JW, Kelly JJ Jr, McConahey WM. Neurologic aspects of thyroid dysfunction. Mayo Clin Proc 1981; 56:504-12.
 
2. Bennett WR, Houston DP. Rhabdomyolysis in thyroid storm. Am J Med 1984; 77:733-5.
http://dx.doi.org/10.1016/0002-9343(84)90375-9
 
3. Duyff RF, Van den Bosch J, Laman DM, van Loon BJ, Linssen WH. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry 2000; 68:750-5.
http://dx.doi.org/10.1136/jnnp.68.6.750
 
4. Horak HA, Pourmand R. Endocrine myopathies. Neurol Clin 2000; 18:203-13.
http://dx.doi.org/10.1016/S0733-8619(05)70186-9
 
5. Kung AW. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab 2006; 91:2490-5.
http://dx.doi.org/10.1210/jc.2006-0356
 
6. Okinaka S, Shizume K, Iino S, et al. The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endocrinol Metab 1957; 17:1454-9.
http://dx.doi.org/10.1210/jcem-17-12-1454
 
7. Kung AW, Ma JT, Yu YL, et al. Myopathy in acute hypothyroidism. Postgrad Med J 1987; 63:661-3.
http://dx.doi.org/10.1136/pgmj.63.742.661
 
8. Suzuki S, Ichikawa K, Nagai M, et al. Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs. Arch Intern Med 1997; 157:693-6.
http://dx.doi.org/10.1001/archinte.1997.00440270147014
 
9. Mizuno H, Sugiyama Y, Nishi Y, et al. Elevation of serum creatine kinase in response to medical treatment of Graves' disease in children. Acta Pediatr 2006; 95:243-5.
http://dx.doi.org/10.1080/08035250500341444
 
10. Shergy WJ, Caldwell DS. Polymyositis after propylthiouracil treatment for hyperthyroidism. Ann Rheum Dis 1988; 47:340-3.
http://dx.doi.org/10.1136/ard.47.4.340
 
11. Page SR, Nussey SS. Myositis in association with carbimazole therapy. Lancet 1989; 1:964.
http://dx.doi.org/10.1016/S0140-6736(89)92550-6
 
12. Shaheen D, Kim CS. Myositis associated with the decline of thyroid hormone levels in thyrotoxicosis: a syndrome? Thyroid 2009; 19:1413-7.
http://dx.doi.org/10.1089/thy.2009.0014
 
13. Pasquier E, Genereau T, Baudrimont M, et al. Biopsy-proven myositis with microvasculitis in association with carbimazole. Lancet 1991; 338:1082-3.
http://dx.doi.org/10.1016/0140-6736(91)91941-M
 
14. Brent GA. Clinical Practice. Grave's disease. N Engl J Med 2008; 358:2594-605.
http://dx.doi.org/10.1056/NEJMcp0801880
 
15. Ryan DP, da Silva MR, Soong TW, et al. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell 2010; 140:88-98.
http://dx.doi.org/10.1016/j.cell.2009.12.024
 
16. Benavides VC, Rivkees SA. Myopathy Associated with Acute Hypothyroidism following Radioiodine Therapy for Graves Disease in an Adolescent. Int J Pediatr Endocrinol 2010; 2010.
×

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.